{
    "nct_id": "NCT03364231",
    "official_title": "A Phase 2 Study to Assess the Efficacy and Safety of TGR-1202 (Umbralisib) Monotherapy in Patients With Non-Follicular Indolent Non-Hodgkin's Lymphoma",
    "inclusion_criteria": "* Confirmed diagnosis of Waldenstroms Macroglobulinemia\n* Relapsed or refractory after at least one prior treatment regimen\n* Eastern Cooperative Oncology Group (ECOG) score of 0 to 2\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Any major surgery, chemotherapy or immunotherapy within the last 21 days\n* Evidence of hepatitis B virus, hepatitis C virus or known HIV infection\n* Prior autologous stem cell transplant within 6 months of study entry",
    "miscellaneous_criteria": ""
}